The efficacy and safety of adjuvant immunotherapy after neoadjuvant immunotherapy combined with chemotherapy in locally advanced resectable esophageal squamous cell carcinoma: a real−world study

BackgroundThe promising therapeutic outcomes of neoadjuvant immunotherapy with chemotherapy (NAIC) in the treatment of resectable locally advanced esophageal squamous cell carcinoma (LA-ESCC) have been confirmed by several clinical trials. However, the potential benefits of adjuvant therapy for LA-E...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Xue Wu, Fangjie Ding, Shunshun Bao, Yiming Mu, Jiandong Zhang, Shuming Zhang, Pingping Hu, Yan Zhang, Ning Liang, Guodong Deng, Yuying Hao, Xinquan Liang, Fengxue Li, Yang Shu, Jingxin Zhang, Lili Qiao, Yingying Zhang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2025-05-01
Saila:	Frontiers in Immunology
Gaiak:	adjuvant therapy neoadjuvant therapy immunotherapy chemotherapy esophageal squamous cell carcinoma (ESCC)
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1555756/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!